Mayzent (siponimod) is a disease-modifying treatment option for relapsing multiple sclerosis (MS) in adults. It can lower the chances of worsening MS and lower the number of MS relapses. Mayzent (siponimod) is a tablet that's taken by mouth. Common side effects include headache, high blood pressure, and falls. Mayzent (siponimod) is currently available as a brand-name only.
Mayzent (siponimod) is a sphingosine 1-phosphate (S1P) receptor modulator. It attaches to the S1P receptor protein found on your white blood cells. This blocks white blood cells from leaving your lymph nodes and releasing into the body.
The exact way Mayzent (siponimod) works to treat MS is unknown. But it's thought to lower the number of white blood cells that reaches your nervous system where they can cause nerve damage.
The following side effects may get better over time as your body gets used to the medication. Let your healthcare provider know immediately if you continue to experience these symptoms or if they worsen over time.
Contact your healthcare provider immediately if you experience any of the following.
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
A clinical study showed that people who took Mayzent (siponimod) had a 21% lower chance of their MS worsening in 3 months than those who took placebo. Mayzent (siponimod) also lowered the number of MS relapses per year by 55%. Keep in mind that some people took Mayzent (siponimod) for almost 2 years in this study. Also be aware that everyone responds differently to medications and you might not necessarily have these same results. Make sure to follow up with your provider regularly to discuss how well Mayzent (siponimod) is working for you.
Your genetic makeup determines how well Mayzent (siponimod) gets broken down (metabolized) in your body. In people who aren't able to metabolize Mayzent (siponimod) as well, the medication can build up in your body and raise your risk of side effects. For this reason, the target dose of Mayzent (siponimod) is lower to help prevent these side effects from happening. Certain people who have even more trouble metabolizing Mayzent (siponimod) can't take this medication because of the risk of serious side effects from high levels of Mayzent (siponimod). Before starting this medication, it's important that you do genetic testing so your provider can find the right dose for you.
Let your provider or pharmacist know right away if you miss a dose. Mayzent (siponimod) can lower your heart rate, which can be more notable if you take the medication after missing doses. If you miss 1 or more doses of Mayzent (siponimod) during the initial ramp-up period, you'll need to restart the medication at the lowest dose. If you're at your target daily dose and miss a dose, take it as soon as you remember. However, if you miss 4 or more target doses in a row, you’ll need to go back to the starting dose and slowly increase your dose again. This will help your body adjust to the medication again so that it doesn't drop your heart rate too much.
Yes, Mayzent (siponimod) is considered an immunosuppressant. It can lower the number of white blood cells in your body, which can weaken your immune system. This can raise your risk of infections. Look out for symptoms of an infection, such as fever, cough, difficulty breathing, diarrhea, or chills, while you're taking Mayzent (siponimod). Let your provider know if you have an infection.
Mayzent (siponimod) and fingolimod (Gilenya) are both disease-modifying therapies used for relapsing forms of MS and are taken by mouth. People who took Mayzent (siponimod) had 55% fewer MS relapses in a year than those who took placebo. And people who took fingolimod (Gilenya) for 2 years had 54% fewer relapses in a year than those who took placebo. Keep in mind that there haven't been any studies so far making direct comparisons about how well the two medications work. As for side effects, Mayzent (siponimod) might have fewer side effects than fingolimod (Gilenya) because it works on fewer types of S1P receptors. Compare the similarities and differences between the two medications. Then, speak with your provider about which medication is right for you.
No. There haven't been enough human studies about how Mayzent (siponimod) affects pregnancy, but animal studies showed that it caused harm to unborn babies. While what happens in animal studies doesn't always happen in humans, it means that there's a potential risk in humans. If you become pregnant during treatment or within 10 days after stopping Mayzent (siponimod), let your provider know. It's also recommended that you enroll in the MotherToBaby Pregnancy Study in Multiple Sclerosis. This program keeps track of your and your baby's health outcomes. Enroll by visiting their website, calling 1-877-311-8972, or emailing MotherToBaby@health.ucsd.edu.
Mayzent (siponimod) has the potential to harm an unborn baby when it's taken during pregnancy. It's recommended to use birth control to avoid pregnancy during treatment and for at least 10 days after the last dose of Mayzent (siponimod). Talk to your provider about forms of birth control that you can use to prevent pregnancy while taking this medication. Let your provider know if you become pregnant during treatment or within 10 days after stopping Mayzent (siponimod).
Talk to your provider about the risks and benefits of taking Mayzent (siponimod) if you're breastfeeding or planning to breastfeed. It's not known whether Mayzent (siponimod) can get into human breast milk and what effects the medication might have on breastfed babies if it does. Because it's not clear how safe it is, your provider can discuss ways to feed your baby as safely as possible while you're taking Mayzent (siponimod).
Mayzent (siponimod) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Mayzent (siponimod) lowers your white blood cell count, which affects your body's ability to fight off infections. This can raise your risk of bacterial, viral, and fungal infections that can sometimes be serious. Make sure you're up-to-date on all of your vaccinations before starting Mayzent (siponimod). If you develop an infection during treatment, your provider will probably ask you to stop taking Mayzent (siponimod) so your body can fight the infection first. Let your provider know if you develop symptoms of an infection, such as fever, cough, difficulty breathing, diarrhea, or chills.
Be aware that you might still be at risk for infections for a few weeks after stopping Mayzent (siponimod). This is because it takes some time for your white blood cell counts to go back to normal after stopping the medication. Continue to look out for symptoms of infection and avoid or limit your time around others who are sick for at least 1 month about stopping Mayzent (siponimod).
Some people developed an eye condition called macular edema while they were taking Mayzent (siponimod). In studies, this eye problem happened within the first 4 months of treatment. Your provider will examine your eyes before and during treatment. Make sure you let them know if you start to have blurry or worsening vision at any time while you're taking Mayzent (siponimod).
Mayzent (siponimod) can temporarily cause your heart rate to slow down when you first start treatment. This can happen within 24 hours after each dose of Mayzent (siponimod) during the initial ramp-up period. In studies, heart rate went back up after the sixth day of treatment. You'll typically go back to your usual heart rate within 10 days of starting Mayzent (siponimod). Let your provider know if you have any heart-related conditions or if you're taking medications that also affect heart rate. In certain situations, your provider will monitor your heart for at least 6 hours after your first dose of Mayzent (siponimod). Get medical help if you have symptoms of low heart rate, such as dizziness, tiredness, weakness, feeling faint, trouble breathing, and chest pain, while you're taking Mayzent (siponimod),
Mayzent (siponimod) can cause breathing problems. This can sometimes happen as early as 3 months after you start the medication. Let your provider know if you have trouble breathing while you're taking Mayzent (siponimod). You might need to do routine breathing tests to check how well your lungs are working.
Mayzent (siponimod) can sometimes cause liver injury. This can happen to anyone, but be sure to tell your provider if you have liver problems before starting treatment. You'll need to do blood work to check your liver health before you start and during Mayzent (siponimod) treatment. If your liver lab results are outside of the normal range, your provider might ask you to stop taking this medication. Typically, your liver health should return to normal after you stop Mayzent (siponimod). Get medical attention right away if you notice symptoms of liver damage, such as loss of appetite, dark urine, stomach pain, or yellowing of the eyes or skin.
Although rare, Mayzent (siponimod) can raise your risk of getting certain types of skin cancer. You'll probably need regular skin exams while you take Mayzent (siponimod). This helps your provider check for your cancer risk. Make sure to wear protective clothing and sunscreen when you're outside, even on cloudy days. Watch out for new moles or skin damage, and report them to your provider if any appear.
Based on animal studies, it's possible that Mayzent (siponimod) can harm a unborn baby when it's taken during pregnancy. Women who can have a child should use birth control to avoid pregnancy during treatment and for at least 10 days after the last dose of Mayzent (siponimod). Let your provider know right away if you become pregnant or think you might be pregnant while you're taking Mayzent (siponimod).
Although rare, there have been reports of a brain problem called posterior reversible encephalopathy syndrome (PRES) in people taking medications like Mayzent (siponimod). So far, there haven’t been reports of PRES in people taking Mayzent (siponimod). But, it's important to be aware of this risk because it can lead to serious complications, such as stroke. Contact your provider right away if you notice a sudden headache, seizures, loss of consciousness, or changes in vision.
| Dosage | Quantity | Price as low as | Price per unit |
|---|---|---|---|
| 0.25mg | 12 tablets | $1,032.15 | $86.01 |
| 2mg | 30 tablets | $10,265.34 | $342.18 |
| 1mg | 30 tablets | $10,265.34 | $342.18 |
Your dose will depend on your genetic makeup, which can affect how well your body can break down the medication. For this reason, you'll need to do genetic testing before starting Mayzent (siponimod) so your provider can choose the appropriate dose for you.
In general, the typical starting dose is 0.25 mg by mouth once daily. Then, your provider will slowly raise your dose over 4 or 5 days to reach the target maintenance dose of 1 mg or 2 mg once daily.
Contraindications are specific health conditions or situations in which a person should not take a medication due to safety concerns. If you have any of the following conditions or if any of the following apply to you, let your healthcare provider know because Mayzent (siponimod) will not be safe for you to take.